Clinical Trial Update: Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating trametinib in patients with advanced solid tumors, including those with liver metastases, with or without hepatic dysfunction; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Tumor of the Liver
• Solid Tumor

Drugs mentioned

• Trametinib (trametinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver | Phase 1 | Status: COMPLETED